Trial of the Pluslife SARS-CoV-2 Nucleic Acid Rapid Test Kit: Prospective Cohort Study

Dandan Zhu   ^{1 *} , MM ;   Jing Huang   ^{2 *} , MM ;   Bei Hu   ^{3 *} , MD ;   Donglin Cao   ^{4 *} , MD ;   Dingqiang Chen   ^{5 *} , MD ;   Xinqiang Song   ^{6 *} , DBA ;   Jialing Chen   ¹ , MM ;   Hao Zhou   ³ , BMed ;   Aiqun Cen   ² , BMed ;   Tieying Hou   ⁷ , MD

¹ Guangdong Center for Clinical Laboratory, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China

² Fever Clinic, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China

³ Department of Emergency Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China

⁴ Department of Laboratory Medicine, Guangdong Second Provincial General Hospital, Guangzhou, China

⁵ Microbiome Medicine Center, Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China

⁶ Party Committee Office and President Office, Guangdong University of Finance and Economics, Guangzhou, China

⁷ Hospital Office, Huazhong University of Science and Technology Union Shenzhen Hospital/Shenzhen Nanshan People’s Hospital, Shenzhen, China

*these authors contributed equally